Heart health, close to home.Serving Greater Philadelphia
HeartAGEHeart Health, Simplified.

The clinical foundation

Established risk models.
Screening with a clearer purpose.

HeartAGE combines measurements and relevant history into an estimated cardiovascular risk assessment, then communicates that estimate as a heart age.

What is supported by the evidence?

Established cardiovascular risk equations, including Framingham models, estimate future cardiovascular risk using combinations of risk factors. CDC researchers have translated a non-laboratory Framingham estimate into predicted heart age. Read the CDC study.

BMI-based and cholesterol-based routes

HeartAGE uses a BMI-based calculation when cholesterol is unavailable and a cholesterol-based calculation when suitable cholesterol results are available. Each approach has its own inputs, intended population, and limitations. Reports should identify the method used; switching methods can change the result even without a change in health.

What does a heart-age result mean?

It expresses an estimated risk relative to a reference risk profile. It is not a direct measurement of the heart’s biological age, a diagnosis of cardiovascular disease, or a substitute for a clinical evaluation.

What does “validated” apply to?

Validation evidence belongs to the specific risk equation, population, inputs, and outcomes studied. That evidence does not automatically validate a branded report, a software implementation, or claims that a workplace event improves outcomes. The calculation must faithfully implement the model and be used within its supported scope.

Screening should connect to action

The clinical plan should define eligibility, measurement quality, confirmation of abnormal results, and referral or follow-up. Aggregate risk reporting requires consistent methods and attention to changes in participants. A change in estimated risk alone does not prove that the program caused better health or lower healthcare spending.

USPSTF recommendations

What the workplace
program can support.

These are clinical preventive recommendations for defined populations. They inform workplace screening components; they are not an endorsement of the HeartAGE brand or a blanket recommendation for annual testing.

ComponentGradePopulationImplementation and limits
Blood-pressure screening ↗AAdults 18+ without known hypertension.Use an appropriate measurement protocol; arrange home or ambulatory confirmation of a possible diagnosis before treatment. Annual screening is suggested for adults 40+ or at increased risk; intervals of 3–5 years may suit lower-risk adults 18–39 with normal prior readings.
Prediabetes / type 2 diabetes ↗BAsymptomatic, nonpregnant adults 35–70 with overweight or obesity; some people warrant earlier or lower-BMI consideration.HbA1c is a nonfasting option; fasting plasma glucose and oral glucose tolerance testing are also specified. Normal results may warrant a three-year interval. Abnormal results need clinical assessment and diagnostic confirmation; prediabetes requires an effective prevention referral.
Lipids and a statin-prevention discussion ↗B / CAdults 40–75 without known CVD, with at least one CVD risk factor.The statin recommendation is B at estimated 10-year CVD risk ≥10%, and C at 7.5% to <10%. This is a clinical medication decision, not a grade for cholesterol testing or for heart age. The recommendation discusses the Pooled Cohort Equations; model endpoints and thresholds must match.
Tobacco use and cessation ↗AAsk all adults about tobacco use.Identify use, advise cessation, and connect participants to evidence-based treatment. Nonpregnant adults may receive behavioral treatment and approved pharmacotherapy through an appropriate clinician; pregnancy requires a tailored pathway. Recording smoking status alone is not the full intervention.
BMI and weight-management referral ↗BAdults with BMI ≥30.The recommendation is to offer or refer to intensive, multicomponent behavioral interventions. Measuring BMI or providing a short handout alone does not deliver that intervention.
Diet and physical-activity counseling ↗BAdults with relevant cardiovascular risk factors.The recommendation explicitly identifies Framingham and Pooled Cohort risk tools as assessment options. Offer or refer eligible adults to effective behavioral counseling; a brief result explanation is not equivalent to a sustained counseling program.

A and B support offering the specified service to eligible people. C indicates selective offering. Grades for counseling or medication apply to those interventions, not merely to collecting a screening measurement. Sources reviewed October 18, 2026; several topics have updates in progress, and current final statements are cited.

Testing frequency

An annual event
does not require annual bloodwork for everyone.

Use age, risk factors, previous screening dates and results, and clinical circumstances to decide what is appropriate. The current USPSTF statin recommendation does not establish a universal annual cholesterol-testing schedule.

A BMI-based heart-age result does not remove a separate clinical indication for lipid or diabetes testing. Conversely, buying a laboratory package does not make every test clinically indicated for every employee.

Screening scope

Risk assessment is intended for an appropriate asymptomatic population. Known cardiovascular disease, symptoms, pregnancy, or ages outside the model’s supported range require an appropriate clinical pathway rather than automatic application of the same score.

Let’s bring HeartAGE to you

Build a screening plan around the people you serve.

Tell us about your workforce, screening needs, and preferred timing.

Get your employer proposal

Sample employee report

Illustrative HeartAGE employee report with estimated heart age, screening measurements, and next steps

Illustrative report. Measurements and recommendations vary by screening program and participant.